For a pharmaceutical company to establish CNS Experimental Medicine Models there would be an immediate requirement to validate novel assays with standards and to develop processes to enable rapid, accurate and reliable throughput of compounds. A cost-effective way for pharmaceutical companies to achieve this goal is to use the expertise of P1vital and its academic network for the validation process. P1vital recognised that the path forward was to establish a Pre-competitive Pharma Consortium in CNS Experimental Medicine. This enables the sharing of initial costs and risks across client companies and subsequent access to a comprehensive database for standards without compromising confidentiality or intellectual property.